Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors Cannabis Investing News
BELLUS Health Announces First Patient Dosed in its Phase 2 BLUEPRINT Trial of BLU-5937 for the Treatment of Chronic Pruritus Associated with Atopic Dermatitis Biotech Investing
Avricore Health Successfully Intergrates ID Now Rapid PCR Test Device, Offering Real-Time Covid-19 Reporting Direct From Instrument for First Time. Medical Device Investing
U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older Pharmaceutical Investing
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 Pharmaceutical Investing
Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme Cannabis Investing News
BAVENCIO® Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Pharmaceutical Investing
CHMP Recommends the Approvals of RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic® for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis Biotech Investing
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer Pharmaceutical Investing
Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID® with Cipla Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness
